Skip to main content

OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC

Written by Customer Service on . Posted in Public Companies.

WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.

OrthoPediatrics’ OPSB division has established a distribution agreement with Thrive Orthopedics LLC focused on three unique pediatric orthotic solutions. The Thrive Orthopedics F3 Hero Pediatric AFO is a lightweight carbon fiber ankle foot orthosis that provides the stability needed to improve walking while allowing flexibility and energy return at the correct moments to produce a more normalized, smooth, and dynamic walking pattern. This type of AFO is indicated for children who have challenges walking due to cerebral palsy, spina bifida, foot drop due to chemotherapy, or many other diagnoses. The TruStretch Pediatric Equinus Brace® is an innovative “above the knee” bracing solution that provides optimal stretching of the gastroc-soleus muscles for children with equinus deformity. The Thrive® Pediatric X-Glide Carbon Fiber Insoles come in both rigid and flexible foot plate styles and offer low profile and lightweight gait training tools.

Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “The OPSB team is starting the new year off with exciting news. I am so proud of everything we are advancing to help more KIDS with non-operative care. The distribution agreement with Thrive Orthopedics represents the next phase of our planned growth, bringing more innovative solutions to children around the world.”

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit https://opsb.com/.

About Thrive Orthopedics
Thrive Orthopedics was founded on one simple premise; to help practitioners and patients by designing and delivering the best carbon fiber AFOs in the world. We believe our products have the best function, craftsmanship, value, and warranty in the entire industry. We are delivering health with compassion and care.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.